Icure Pharmaceutical Incorporation (KOSDAQ:175250)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,170.00
+231.00 (11.91%)
At close: Aug 5, 2025

KOSDAQ:175250 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
8,27017,1846,33250,56917,806
Short-Term Investments
2,7405,250340.19360.19745
Trading Asset Securities
-2.191,8862,8565,866
Cash & Short-Term Investments
11,01022,4378,55853,78624,417
Cash Growth
-50.93%162.17%-84.09%120.28%77.99%
Accounts Receivable
12,99910,5827,7268,17410,153
Other Receivables
208.85729.74194.11509.921,774
Receivables
13,20812,7728,76015,88416,978
Inventory
8,92012,89713,01910,54616,977
Prepaid Expenses
134.45139.83116.2180.58129.48
Other Current Assets
1,164326.62654.81408.36294.83
Total Current Assets
34,43648,57231,10880,70558,796
Property, Plant & Equipment
48,79464,52993,52696,943101,312
Long-Term Investments
871.971,6599,41611,00122,675
Goodwill
-1,6012,8582,8584,150
Other Intangible Assets
425.921,8292,3812,9803,081
Long-Term Accounts Receivable
-83.93---
Long-Term Deferred Tax Assets
-1,172774.48530.59-
Long-Term Deferred Charges
-5,0309,0209,7018,622
Other Long-Term Assets
4,6618,52617,14418,41216,794
Total Assets
90,500133,618166,844224,121215,448
Accounts Payable
8,1666,6857,2916,4616,155
Accrued Expenses
513.9700.15755.32718.82496.54
Short-Term Debt
20,54032,16956,27673,52110,050
Current Portion of Long-Term Debt
1,0191,55612,7663,74732,120
Current Portion of Leases
1,3111,23477.56171.09185.44
Current Unearned Revenue
-242.6106.0823.75-
Other Current Liabilities
23,91621,74715,77425,3395,811
Total Current Liabilities
55,46664,33393,045109,98154,818
Long-Term Debt
666.634,3524,8629,45031,650
Long-Term Leases
4,1181,12934.72120.83180.31
Pension & Post-Retirement Benefits
508.82-5,9072,8782,465
Long-Term Deferred Tax Liabilities
----16.36
Other Long-Term Liabilities
2,2202,1122,8529,83327,615
Total Liabilities
62,98071,927106,700132,262116,744
Common Stock
18,77918,77918,77918,7799,446
Additional Paid-In Capital
134,882133,428133,401133,434107,271
Retained Earnings
-124,907-91,382-93,734-60,603-18,969
Treasury Stock
-3,707-3,707-3,707-3,707-3,160
Comprehensive Income & Other
1,2981,3941,6571,7691,168
Total Common Equity
26,34558,51256,39589,67195,755
Minority Interest
-1,888471.811,3552,1882,949
Shareholders' Equity
27,52061,69160,14491,85998,704
Total Liabilities & Equity
90,500133,618166,844224,121215,448
Total Debt
27,65540,44074,01587,00974,186
Net Cash (Debt)
-16,645-18,003-65,457-33,224-49,769
Net Cash Per Share
-444.36-481.04-1742.81-1426.23-2298.37
Filing Date Shares Outstanding
37.0537.3737.3737.3722.51
Total Common Shares Outstanding
37.0537.3737.3737.3722.51
Working Capital
-21,030-15,762-61,937-29,2763,979
Book Value Per Share
711.001565.771509.112399.564254.76
Tangible Book Value
25,91955,08151,15683,83288,524
Tangible Book Value Per Share
699.511473.961368.912243.323933.45
Land
5,6748,30525,62624,37825,388
Buildings
38,86047,34652,38452,05350,835
Machinery
22,22732,62736,26533,83030,572
Construction In Progress
395.41,209259.66917.823,422
Source: S&P Global Market Intelligence. Standard template. Financial Sources.